
Join to View Full Profile
107 Spring StreetSuite 510Seattle, WA 98104
Dr. Quay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1978 - 1980
- University of Michigan Medical SchoolClass of 1977
Certifications & Licensure
- DC State Medical License Current
- DE State Medical License Current
- VT State Medical License Current
- NH State Medical License 2012 - Present
- WA State Medical License 1995 - 2026
- CA State Medical License 1980 - 2025
- MA State Medical License 1979 - 2025
- American Board of Pathology Anatomic Pathology
- Join now to see all
Publications & Presentations
PubMed
- A Hypothesized Therapeutic Role of (Z)-Endoxifen in Duchenne Muscular Dystrophy (DMD).H Lawrence Remmel, Sandra S Hammer, Laurence A Neff, Olivier M Dorchies, Leonardo Scapozza
Degenerative Neurological and Neuromuscular Disease. 2025-01-01 - 9 citationsProliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: a systematic reviewJohn Hornberger, Shu-Chih Chen, Qianyi Li, Priyanka Kakad, Steven C. Quay
Current Medical Research and Opinion. 2015-02-01 - 11 citationsDevelopment of Calcitonin Salmon Nasal Spray: Similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservativeHenry R. Costantino, Heather Culley, Lishan Chen, Daniel Morris, Michael E. Houston
Journal of Pharmaceutical Sciences. 2009-10-01
Press Mentions
- Happy Hour Continues: Alcohol and Breast Cancer AdvisoryJanuary 9th, 2025
- Happy Hour Is on the Rocks: Alcohol and Breast Cancer AdvisoryJanuary 8th, 2025
- Atossa to Present a Trial in Progress Poster on Its Neoadjuvant Breast Cancer Phase 2 Clinical Trial, EVANGELINE, at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingMay 9th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: